# Sebastien Latapie

> Sebastien Latapie is a seed investor at Dynamk Capital backing Biotechnology. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Dynamk Capital](https://shizune.co/investors/profile/dynamk-capital)
- Location: New York, United States
- Total investments: 2
- Last investment: May 2025
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/sebastienlatapie

Sebastien Latapie is a seed investor at Dynamk Capital in New York focused on Biotechnology and Artificial Intelligence. Sebastien Latapie is the Principal at Dynamk Capital.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 1 | 50% |
| Artificial Intelligence | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Series A | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Intrepid Labs | Intrepid Labs was spun out of the University of Toronto to pioneer the use of artificial intelligence and robotics to redefine drug formulation and accelerate therapeutic development. | $7M | Seed | May 12, 2025 |  |
| PathPresenter | PathPresenter is a global image-sharing platform for pathology. Its mission is to democratize access to pathology knowledge by building roads and bridges to share image data, AI algorithms, and domain expertise. | $7.5M | Series A | Sep 12, 2024 |  |

2 of 2 investments shown.

## Co-investors
- [Barco](https://shizune.co/investors/profile/barco) — VC Fund, 1 deal together
- [Modi Ventures](https://shizune.co/investors/profile/modi-ventures) — VC Fund, 1 deal together

## About Dynamk Capital

VC Fund · New York, United States

Dynamk Capital invests in innovative tools and technologies that are critical for the discovery, development and production of life-saving therapies.We partner with life science visionaries whose market-defining ideas are shaping the future of how therapeutics are being developed, increasing access for patients, and reducing costs.

4 contacts available at Dynamk Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Daniella Kranjac | Founding Partner | https://shizune.co/investors/profile/daniella-kranjac |
| Reinhard Vogt | Managing Director | https://shizune.co/investors/profile/reinhard-vogt |
| Gustavo Mahler | Venture Partner | https://shizune.co/investors/profile/gustavo-mahler |
| Sebastien Latapie | Principal | https://shizune.co/investors/profile/sebastien-latapie |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Sebastien Latapie invest in?

Sebastien Latapie invests primarily in Biotechnology and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Sebastien Latapie last invest?

The most recent investment recorded for Sebastien Latapie closed in May 2025. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co